Verrica Pharmaceuticals announced that CEO Jayson Rieger will present at the Jefferies Global Healthcare Conference on June 4, 2026, in New York. The company develops treatments for dermatological diseases, including its FDA-approved product YCANTH® for molluscum contagiosum and ongoing development for common warts and non-melanoma skin cancers. The presentation will be webcast live and available for replay, providing investors insight into Verrica's progress and pipeline.
The National Advertising Division (NAD) upheld Spectrum's claim that customers can receive free high-speed internet forever by purchasing and maintaining four mobile lines. However, NAD recommended that Spectrum clearly disclose key terms, such as th...
Virgin Galactic's stock jumped from $2.47 to $6.18 in nine trading days, driven by a successful glide test, a court settlement, and analyst support for its 2026 commercial launch. The rally triggered a short squeeze as retail investors piled in, push...
SoftBank CEO Masayoshi Son claims the AI revolution is 50 times bigger than the dot-com boom and views inevitable market corrections as the best investment opportunities. He compares the current AI surge to the early internet era and highlights SoftB...
Micron Technology saw its stock price jump 87.76% in May, marking its best monthly gain since November 1985, driven by strong demand for AI infrastructure and memory products. Despite this historic rally, June has traditionally been a weak month for ...
The Hanover Insurance Group announced a quarterly dividend of $0.95 per common share, payable on June 26, 2026, to shareholders of record as of June 12, 2026. This dividend reflects the company's ongoing commitment to returning value to shareholders....
